192 related articles for article (PubMed ID: 36648496)
21. Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy.
van den Broek SL; Shalgunov V; Herth MM
Biomater Adv; 2022 Oct; 141():213125. PubMed ID: 36182833
[TBL] [Abstract][Full Text] [Related]
22. Dendrimer technologies for brain tumor.
Mishra V; Kesharwani P
Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979
[TBL] [Abstract][Full Text] [Related]
23. Targeting specific cells in the brain with nanomedicines for CNS therapies.
Zhang F; Lin YA; Kannan S; Kannan RM
J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
[TBL] [Abstract][Full Text] [Related]
24. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
Mangraviti A; Gullotti D; Tyler B; Brem H
J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
[TBL] [Abstract][Full Text] [Related]
25. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.
May JN; Golombek SK; Baues M; Dasgupta A; Drude N; Rix A; Rommel D; von Stillfried S; Appold L; Pola R; Pechar M; van Bloois L; Storm G; Kuehne AJC; Gremse F; Theek B; Kiessling F; Lammers T
Theranostics; 2020; 10(4):1948-1959. PubMed ID: 32042346
[No Abstract] [Full Text] [Related]
26. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract][Full Text] [Related]
27. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
[TBL] [Abstract][Full Text] [Related]
28. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
[TBL] [Abstract][Full Text] [Related]
29. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation.
Gu W; Meng F; Haag R; Zhong Z
J Control Release; 2021 Jan; 329():676-695. PubMed ID: 33022328
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine for glioblastoma: Progress and future prospects.
Khan I; Baig MH; Mahfooz S; Imran MA; Khan MI; Dong JJ; Cho JY; Hatiboglu MA
Semin Cancer Biol; 2022 Nov; 86(Pt 2):172-186. PubMed ID: 35760272
[TBL] [Abstract][Full Text] [Related]
31. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine.
Sharma HS; Muresanu DF; Castellani RJ; Nozari A; Lafuente JV; Tian ZR; Sahib S; Bryukhovetskiy I; Bryukhovetskiy A; Buzoianu AD; Patnaik R; Wiklund L; Sharma A
Int Rev Neurobiol; 2020; 151():1-66. PubMed ID: 32448602
[TBL] [Abstract][Full Text] [Related]
33. Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy.
Wang L; Shi Y; Jiang J; Li C; Zhang H; Zhang X; Jiang T; Wang L; Wang Y; Feng L
Small; 2022 Nov; 18(45):e2203678. PubMed ID: 36103614
[TBL] [Abstract][Full Text] [Related]
34. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
35. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
36. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X
Small; 2017 Nov; 13(43):. PubMed ID: 29045030
[TBL] [Abstract][Full Text] [Related]
37. Bioinspired and Biomimetic Nanomedicines.
Chen Z; Wang Z; Gu Z
Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
[TBL] [Abstract][Full Text] [Related]
38. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
